Cargando…
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
BACKGROUND: Concurrent germline (g) pathogenic variants related to hereditary breast cancer represent a rare occurrence. While double heterozygosity in gBRCA1 and gBRCA2 has been reported in the past, herein we describe the first case of three known concurrent pathogenic variants identified in a fam...
Autores principales: | Sukumar, Jasmine, Kassem, Mahmoud, Agnese, Doreen, Pilarski, Robert, Ramaswamy, Bhuvaneswari, Sweet, Kevin, Sardesai, Sagar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990865/ https://www.ncbi.nlm.nih.gov/pubmed/33507482 http://dx.doi.org/10.1007/s10549-021-06095-w |
Ejemplares similares
-
CHEK2 contribution to hereditary breast cancer in non-BRCA families
por: Desrichard, Alexis, et al.
Publicado: (2011) -
Multitumor Case Series of Germline BRCA1, BRCA2 and CHEK2-Mutated Patients Responding Favorably on Immune Checkpoint Inhibitors
por: Kinget, Lisa, et al.
Publicado: (2021) -
Screening for germline BRCA1, BRCA2,
TP53 and CHEK2 mutations in families at-risk for
hereditary breast cancer identified in a population-based study from Southern
Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2016) -
Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population
por: Felix, Gabriela ES, et al.
Publicado: (2014) -
In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2
por: Kim, S, et al.
Publicado: (2008)